Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use
Context: Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are a novel treatment approved for type 2 diabetes mellitus to lower hyperglycemia, systolic blood pressure, and promote weight loss. Commonly reported serious adverse events include increased mycotic urogenital infections, orthostatic hyp...
| Những tác giả chính: | , , , |
|---|---|
| Định dạng: | Bài viết |
| Ngôn ngữ: | English |
| Được phát hành: |
Greater Baltimore Medical Center
2018-09-01
|
| Loạt: | Journal of Community Hospital Internal Medicine Perspectives |
| Những chủ đề: | |
| Truy cập trực tuyến: | http://dx.doi.org/10.1080/20009666.2018.1527667 |